SEAGULL HEALTH
Your health,We care!
Savolitinib is characterized by precise targeting, definite clinical benefits, and manageable safety profile.
AuthenticGuaranteeFast DeliveryPrivacy Savolitinib is a selective MET inhibitor, primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) h···【Read More】
Update: 23 Jan,2026Source: Haiou HealthViews: 81
Savolitinib is a targeted therapy agent indicated for specific malignancies. Common side effects include nausea, edema, abnormal liver and renal funct···【Read More】
Update: 23 Jan,2026Source: Haiou HealthViews: 80
The standard administration of Savolitinib is oral. The recommended dose is 300 mg once daily, to be taken on an empty stomach (1 hour before meals or···【Read More】
Update: 23 Jan,2026Source: Haiou HealthViews: 75
Savolitinib is a targeted therapy for specific types of lung cancer, primarily indicated for patients with advanced non-small cell lung cancer (NSCLC)···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 78
During the course of Savolitinib treatment, it is necessary to avoid grapefruit - like fruits, alcohol, and high - fat foods, and adjust your diet in ···【Read More】
Update: 23 Jan,2026Source: Haiou HealthViews: 84
Savolitinib is a targeted therapy primarily indicated for the treatment of specific subtypes of non-small cell lung cancer (NSCLC). Dosing regimens fo···【Read More】
Update: 23 Jan,2026Source: Haiou HealthViews: 74
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
